When pain relief is needed, the agents lessen bleeding risks compared with nonselective NSAIDs, observational data suggest.
The trend is amplified by an aging population that becomes increasingly vulnerable to CVD tied to rising temperatures.
The results support the potential to change the trajectory of kidney function decline and extend life expectancy.
May is a busy but invigorating season for the TCTMD team—in-person connections abound and the stream of data never stops. The ...
A meta-analysis suggests adverse events are often falsely attributed to BP-lowering drugs, leaving patients undertreated.
Durability questions remain, but Myval appears comparable to contemporary devices on the market, says Patrick Serruys.
The curves for TVF separated early and remained parallel in the complex cases, giving an advantage to the DCB group at 1 year ...
After the sponsor halted the trial, despite the DSMB’s advice to continue, investigators aimed to salvage the scientific value.
Women continue to be underdiagnosed and undertreated for cardiovascular disease around the world—to overcome this gap, a new joint statement from the European Society of Cardiology (ESC) and other ...
This month: questionable value of management consultants, BP across the lifespan, patient frailty perspectives in HF, and more.
Top-line results from the phase III trial show average weight losses of 19% to 28.3% by 80 weeks depending on dose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results